Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Multiple Sclerosis and Related Disorders|September 2, 2019
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosisCavit Boz, Murat Terzi, Bilge Özer, et al.Neurology|March 6, 2024
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based StudyTim Spelman, Gabrielle Simoneau, Robert Hyde, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 23, 2013
Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosisCharlotte Teunissen, Til Menge, Ayse Altintas, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.Therapeutic Advances in Neurological Disorders|July 14, 2020
Sex effects across the lifespan in women with multiple sclerosisKristen M Krysko, Jennifer S Graves, Ruth Dobson, et al.Neurology and Therapy|July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysisMahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.Neurodegenerative Disease Management|June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2022
Early predictors of disability in paediatric multiple sclerosis: evidence from a multi-national registrySifat Sharmin, Charles B Malpas, Izanne Roos, et al.Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.Pageof 8